| NEW! REVIEWS Based on your feedback, we’ve added a Reviews section to Extracellular Matrix News | Matrix Control of Transforming Growth Factor-β Function Authors discuss recent findings concerning the relationship of transforming growth factor-beta (TGF-β), extracellular matrix molecules, and latent TGF-β activation and propose a model to resolve the “TGF-β paradox.” [J Biochem] Abstract |
| INDUSTRY NEWS | BioTime Obtains Expanded License to HyStem® Technology BioTime, Inc. announced that the company has amended its license from the University of Utah to expand the field of use for which BioTime is licensed to produce and market products covered by the core patents underlying HyStem® technology. HyStem®-Rx is a biocompatible, implantable hyaluronan and collagen-based matrix for cell delivery in human clinical applications. [BioTime, Inc.] Press Release Anne-Marie Duliege Appointed to Governing Board of California’s Stem Cell Agency Anne-Marie Duliege, MD, Chief Medical Officer of Affymax Inc., has been appointed to the Independent Citizens Oversight Committee, the governing board of California’s stem cell agency, the California Institute for Regenerative Medicine. [California Institute for Regenerative Medicine] Press Release |
|
|
|